Diabetes Patients
- All
- News
- Videos
- Web Stories
-
Breakthrough Brain Cancer Therapy Shows Dramatic Tumour Shrinking In 5 Days In Early Trial
CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing them back into the body.
-
Metformin For PCOS: How Does This Diabetes Drug Help Manage Symptoms?
Metformin is a prescription medication traditionally used to treat type 2 diabetes by managing blood sugar levels. It works primarily by decreasing glucose production in the liver, improving the body's sensitivity to insulin.
-
Water Fasting For Detox And Weight Loss Can Be Dangerous, Apollo Doctor Warns
Anshuman Kaushal reveals five better options than water fasting that can significantly boost health.
-
Can Makhana Or Fox Nuts Keep You Full Without The Insulin Spike?
Makhana, or fox nuts, have the ability to keep you full for long hours. The key is to consume a controlled portion and in a form that maintains its nutritional integrity.
-
Fatty Pancreas Detected In Nearly 50% Of Type 2 Diabetes Patients, Finds Study
A recent study has found that nearly 54% of patients with type 2 diabetes (T2D) suffer from fatty pancreas disease (FPD).
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
GLP-1 Users Often Restart Medication After Stopping, Finds Study; What Exactly Happens After Quitting?
The study found that a significant portion of patients who discontinued the drug actually went back to treatment within a year.
-
Jan Aushadhi Kendra In Jamtara Provides Affordable Medicines To Poor, Middle-Class People, Drawing Over 200 Patients Daily
The Jan Aushadhi Kendra located near Veer Kunwar Chowk in Jamtara district of Jharkhand, is fast emerging as a major relief for poor and middle-class people, ensuring that affordable and quality medicines reach the general public.
-
Breakthrough Brain Cancer Therapy Shows Dramatic Tumour Shrinking In 5 Days In Early Trial
CAR-T therapy works by taking a patient's immune cells, modifying them in a lab to better recognise cancer, and then infusing them back into the body.
-
Metformin For PCOS: How Does This Diabetes Drug Help Manage Symptoms?
Metformin is a prescription medication traditionally used to treat type 2 diabetes by managing blood sugar levels. It works primarily by decreasing glucose production in the liver, improving the body's sensitivity to insulin.
-
Water Fasting For Detox And Weight Loss Can Be Dangerous, Apollo Doctor Warns
Anshuman Kaushal reveals five better options than water fasting that can significantly boost health.
-
Can Makhana Or Fox Nuts Keep You Full Without The Insulin Spike?
Makhana, or fox nuts, have the ability to keep you full for long hours. The key is to consume a controlled portion and in a form that maintains its nutritional integrity.
-
Fatty Pancreas Detected In Nearly 50% Of Type 2 Diabetes Patients, Finds Study
A recent study has found that nearly 54% of patients with type 2 diabetes (T2D) suffer from fatty pancreas disease (FPD).
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
Heart Benefits Fade After You Stop Taking GLP-1 Drugs: Study
This study, published in BMJ Medicine, investigated what happens when people with Type 2 diabetes stop or interrupt their treatment with GLP-1 drugs.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
GLP-1 Users Often Restart Medication After Stopping, Finds Study; What Exactly Happens After Quitting?
The study found that a significant portion of patients who discontinued the drug actually went back to treatment within a year.
-
Jan Aushadhi Kendra In Jamtara Provides Affordable Medicines To Poor, Middle-Class People, Drawing Over 200 Patients Daily
The Jan Aushadhi Kendra located near Veer Kunwar Chowk in Jamtara district of Jharkhand, is fast emerging as a major relief for poor and middle-class people, ensuring that affordable and quality medicines reach the general public.
